KEQU
Kewaunee Scientific Corporation
KEQU trails on the overall score without a compensating advantage in the available component scores.
NKE
NIKE, Inc.
NKE has the edge over KEQU overall, supported by stronger valuation and lower modeled downside.
KEQU Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Strong |
KEQU's balance sheet is currently strong, and its revenue and profitability are stable, but its cash flow is under pressure.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
KEQU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.5x | $20.79 | -42% |
| Fair | 11x | $29.03 | -19% |
| Expensive | 13x | $36.49 | +1.5% |
| Current | 13x | $35.94 | — |
Historical ranges are pointers, not guarantees.
KEQU's PE is in its expensive range at 13x.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over KEQU in the historical PE scenario, which offers more potential upside but is not a forecast.
KEQU Forward outlook
There aren't enough analyst estimates for KEQU to show an outlook.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
KEQU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.76 | -33% |
| Q2 2026 | $3.22 | -16% |
| Q1 2026 | $3.72 | -37% |
| Q4 2025 | $3.94 | -38% |
| Q3 2025 | $4.13 | -34% |
| Q2 2025 | $3.83 | -40% |
| Q1 2025 | $5.94 | +98% |
| Q4 2024 | $6.34 | +164% |
KEQU's earnings per share have fallen from their peak: $2.76 over the past year, against $6.38 in early 2024.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
KEQU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $66.3M | -6.7% |
| Q2 2026 | $71.4M | -7.5% |
| Q1 2026 | $69.4M | +3.3% |
| Q4 2025 | $70.1M | +47% |
| Q3 2025 | $71.1M | +47% |
| Q2 2025 | $77.1M | +36% |
| Q1 2025 | $67.2M | +44% |
| Q4 2024 | $47.8M | -5.3% |
KEQU has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.8% | -2 points |
| Q2 2026 | 7.3% | -3.7 points |
| Q1 2026 | 3.7% | +0.4 points |
| Q4 2025 | 5.9% | -3.4 points |
| Q3 2025 | 6.8% | +1.4 points |
| Q2 2025 | 11% | +1.2 points |
| Q1 2025 | 3.4% | -4.8 points |
| Q4 2024 | 9.3% | -0.9 points |
KEQU's operating margin was 4.8% last quarter, down 2 points from the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over KEQU on profitability, with a higher operating margin.
KEQU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2M | -76% |
| Q2 2026 | $4.5M | -49% |
| Q1 2026 | $11M | +$13.9M |
| Q4 2025 | -$5.8M | -175% |
| Q3 2025 | $5M | +$6.1M |
| Q2 2025 | $8.9M | +5256% |
| Q1 2025 | -$3M | -133% |
| Q4 2024 | $7.8M | +$8.3M |
KEQU has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
KEQU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.1% | -62K shares |
| 1 year | -1.4% | -42K shares |
| 3 years | +1.2% | +36K shares |
| 5 years | +5.2% | +144K shares |
| Available history | +6.2% | +171K shares |
KEQU has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $529,000 |
| Q2 2025 | $1.6M |
| Q2 2024 | $1.2M |
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
KEQU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.9x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 1.1x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | -1.3x | Net Cash |
KEQU's net debt is less than a year of its operating earnings (EBITDA).
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over KEQU on leverage, with a lower net debt burden relative to earnings.
KEQU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.8 | Neutral |
| Stochastic | 35.7 | Neutral |
KEQU's weekly RSI is 51 (neutral) and its Stochastic is 36 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
KEQU PE vs Consumer Cyclical Sector
| Metric | KEQU | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 18x | 28% below |
| PE % | 81 | 47 | 34 pts above |
KEQU has the edge over NKE on valuation relative to its sector.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
KEQU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.9 | 6% above |
| 20 week MA | $35.4 | 1.5% above |
| 50 week MA | $37.0 | 2.9% below |
| 100 week MA | $42.5 | 15% below |
| 200 week MA | $35.1 | 2.4% above |
KEQU has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
KEQU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.1 | $10.6 | -19% |
| 2021 | $10.6 | $12.3 | +16% |
| 2022 | $12.3 | $15.8 | +28% |
| 2023 | $15.8 | $29.1 | +85% |
| 2024 | $29.1 | $63.8 | +120% |
| 2025 | $63.8 | $38.0 | -40% |
| 2026 YTD | $38.0 | $35.9 | -5.4% |
KEQU has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.